Technical Description
The technology introduces a simple hollow mesoporous chiral polymeric nanocapsule. It involves the preparation of a hollow core with mesopores on a poly N-acryloyl L phenylalanine methyl ester polymer shell that contains active pharmaceutical medicines or biological substances for biomedical applications.
Problems Addressed
- Lack Precision Targeting
- Poor Biocompatibility
- Low Biodegradability
- Safety Issues
- High Toxicity
Tech Features
- Hollow Mesoporous Structure
- Chiral Polymeric Composition
- Active Drug Encapsulation
- Suitable for Targeted Therapy
- Antimicrobial Delivery System
- Tumour Growth Suppression
Target Audience
- Healthcare & Medical Sector
- Medical Device Manufacturers
- Pharmaceutical Industry
- Biotechnology Sector
- Research & Development
Tech ID: P27-1351 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
